Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00450
Full Text
Open PDFAbstract
Available in full text
Date
June 13, 2019
Authors
Publisher
Frontiers Media SA